Research on the effectiveness and tolerability of vaginal administration of probiotic Lactobacillus acidophilus in women with symptoms of colpitis;Ispitivanje djelotvornosti i podnošljivosti vaginalne primjene probiotika Lactobacillus acidophilus u žena sa simptomima kolpitisa

Infektoloski Glasnik

Volumn 27, Issue 2, 2007, Pages 81-85

  Škerk, Višnja ^a   Tambić Andrašević, Arjana ^a   Ferinčević, Rosa ^b   Tomac, Gordana ^a   Škerk, Vedrana ^c   Škalko, Davorin ^a   Perović, Marta ^a   Topić, Antea ^a   Vicković, Ninoslava ^a   Andrašević, Saša ^a   Milošević, Velimir ^a   Begovac, Josip ^a  

^a Croatia

^b MarinaLab

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Clinical use; Colpitis; Lactobacillus acidophilus; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESEARCH; DRUG TOLERABILITY; FEMALE; HUMAN; LACTOBACILLUS ACIDOPHILUS; PROSPECTIVE STUDY; SKIN IRRITATION; SYMPTOM; VAGINAL PRURITUS; VAGINITIS;

EID: 34548808612     PISSN: 13312820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. FAO/WHO: www.fao.org/es/ESN/Probio/probio.htm
2. Macfarlane GT, Cummings JH. Probiotics, infection and immunity. Curr Opin Infect Dis 2002;15:501-6.
3. De Simone C, Vesely R, Bianchi SB i sur. The role of probiotics in modulation of the immune system in man and in animals. Int J Ammunother 1993;9:23-8.
4. Isenberg HD, Berkman JI, Carito SL. Factors leadaing to overt monilial disease II: retardation of growth of Candida albicans by methabolic and products of intestinal bacteria. Antimicrob Agents Ann 1960;10:570-5.
5. Will TE. Lactobacillus overgrowth for treatment of moniliary vulvovaginitis. Lancet 1979;2:482.
6. Sandler B. Lactobacillus for vulvovaginitis. Lancet 1979;2:791-2.
7. Hilton E, Isenberg HD, Alperstein P, France K, Borenstein MT. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992;116:353-7.
8. Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP. Lactobacillus acidophilus inhibits growth of Campy lobacter pylori in vitro. J Clin Microbiol 1989;27:2328-30.
9. Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 1990;3:335-44.
10. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001;73:437S-43.
11. Brlečić M, Škerk V, Miloŝević V i sur. Iskustva u primjeni pripravka Acidosalus® - fermentiranog mliječnog probiotika s Lactobacillus acidophilus. 8. simpozij o spolno prenosivim bolestima i urogenitalnim infekcijama. Opatija; 2006, str. 16, No 9.
12. Škerk V, Tambić-Andrašević A, Ferinčević R i sur. Djelotvornost profilaktičke vaginalne primjene acidosalusa u ẑena s rekurentnim cistitisom. 9. simpozij o spolno prenosivim bolestima i urogenitalnim infekcijama. Opatija; 2007, str. 11, No 6.
13. Williams AB, Yu C, Tashima K, Burgess J, Danvers K. Evaluation of two self-care treatments for prevention of vaginal candidiasis in women with HIV. J Assoc Nurses AIDS are 2001;12:51-7.
14. Fredricsson B, Englund K, Weintraub L, Olund A, Nord CE. Bacterial vaginosis is not a simple ecological disorder. Gynecol Obstet Invest 1989;28:156-60.
15. Marrazzo JM, Cook RL, Weisenfeld HC i sur. Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. J WOMENS Health 2006;15:1053-60.
16. Drago L, De Vecchi E, Nicola L, Zucchetti E, Gismondo MR, Vicariotto F. Activity of a Lactobacillus acidophilus-based douche for the treatment of bacterial vaginosis. J Altern Complement Med 2007;13:435-8.
17. Barbes C, Boris S. Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDS 1999;13:747-51.
18. Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 1990;3:335-44.
19. Hoyme UB, Saling E. Efficient prematurity prevention is possible by pH-self measurement and immediate therapy of threatening ascending infection. Eur J Obstet Gynecol Reprod Biol 2004;115:148-53.
20. Hoyme UB, Saling E. Efficient prevention of prematurity - the Thuringian model. Gynakol Geburtshilfliche Rundsch 2004:44:2-9.
21. Othman M, Neilson JP, Alfirevic Z. Probiotics for preventing preterm labour. Cochrane Database Syst Rev 2007;1:CD005941.